Mesenchymal stem/stromal cells (MSCs) are a promising resource for cell-based therapy
because of their high immunomodulation ability, tropism towards inflamed and injured …

Mesenchymal stem cells (MSCs) are among the most frequently used cell type for
regenerative medicine. A large number of studies have shown the beneficial effects of MSC …

The human umbilical cord is a promising source of mesenchymal stem cells (HUCMSCs).
Unlike bone marrow stem cells, HUCMSCs have a painless collection procedure and faster …

Wharton's jelly (WJ) is a gelatinous tissue within the umbilical cord that contains
myofibroblast-like stromal cells. A unique cell population of WJ that has been suggested as …

The human umbilical cord that originates from the embryo is an extra-embryonic membrane
and the Wharton's jelly within it is a rich source of stem cells (hWJSCs). It is not definitely …

Cancer stands as one of the most leading causes of death worldwide, while one of the most
significant challenges in treating it is revealing novel alternatives to predict, diagnose, and …

Mesenchymal stem cells (MSCs) from bone marrow, adult organs and fetuses face the
disadvantages of invasive isolation, limited cell numbers and ethical constraints while …

Several studies suggest that mesenchymal stem cells (MSCs) possess antitumor properties;
however, the exact mechanisms remain unclear. Recently, microvesicles (MVs) are …

Around 5 million annual births in EU and 131 million worldwide give a unique opportunity to
collect lifesaving Wharton's jelly derived mesenchymal stem cells (WJ‐MSC). Evidences that …

We speculate that exosomes derived from human umbilical cord mesenchymal stromal cells
(HUC-MSCs) will accumulate within tumors and have the potential for both tumor location or …